Kevin Sprott

Kevin has over 20 years of experience as a medicinal chemist leading projects and companies up and through clinical study. Prior to joining Stablix, Kevin provided his expertise to companies such as Syros, Verastem, Ironwood, and Millennium. Kevin and his teams have delivered 9 development candidates in diverse therapeutic areas, including oncology, immunology and pain.